Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Harvard Business School
Johnson and Johnson
Queensland Health
Express Scripts
Daiichi Sankyo
Chinese Patent Office

Generated: January 23, 2019

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 022290

« Back to Dashboard

NDA 022290 describes ADREVIEW, which is a drug marketed by Ge Healthcare and is included in one NDA. It is available from one supplier. Additional details are available on the ADREVIEW profile page.

The generic ingredient in ADREVIEW is iobenguane sulfate i-123. One supplier is listed for this compound. Additional details are available on the iobenguane sulfate i-123 profile page.
Summary for 022290
Applicant:Ge Healthcare
Ingredient:iobenguane sulfate i-123
Suppliers and Packaging for NDA: 022290
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
ADREVIEW iobenguane sulfate i-123 SOLUTION;INTRAVENOUS 022290 NDA Medi-Physics Inc. 17156-235 17156-235-01 1 VIAL, GLASS in 1 CONTAINER (17156-235-01) > 5 mL in 1 VIAL, GLASS

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:SOLUTION;INTRAVENOUSStrength10mCi/5ML (2mCi/ML)
Approval Date:Sep 19, 2008TE:RLD:Yes

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Queensland Health
Boehringer Ingelheim
Daiichi Sankyo

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.